Certara
Certara is a biosimulation and technology-enabled drug development company that provides software, consulting, and regulatory services to pharmaceutical, biotech, and regulatory agency clients to improve the efficiency and success rates of bringing new therapies to market. Its offerings include model-informed drug development platforms, pharmacometrics and regulatory strategy consulting, and real-world evidence and market access solutions, sold primarily via software licenses, SaaS subscriptions, and professional services engagements.
- Revenue
- $250M - $1B
- Employees
- 1,001 - 5,000
- Founded
- 2008
- Headquarters
- Princeton, United States of America
Certara customers on Arbolus
Customers who reviewed Certara
Seniority of Certara customers
The largest group of people who reviewed Certara holds Director roles (50%), followed by C-Suite (39%) and Manager (11%).
- Director 50%
- C-Suite 39%
- Manager 11%
Customers sample
Employer names and spend open in the full report, along with the other 16 customers.
What 19 Arbolus experts think of Certara
Overall sentiment: Positive
NPS distribution shows 47.4% Promoters, 42.1% Passives, and 10.5% Detractors, with an NPS score of 36.8 and average NPS of 8.16. Renewal intent is split: 46.7% Yes, 6.7% No, and 46.7% Not Sure. 73.7% of customers are in the more-than-a-year implementation stage, indicating strong stickiness, but nearly half are unsure about renewal. Key feedback themes include high regulatory credibility, reliability, and cost concerns, with growing interest in automation and AI integration.
Everything 19 customers told us about Certara.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
36 Net Promoter Score, from 19 scored reviews- Promoters 9
- Passives 8
- Detractors 2
Praised
- AI and Automation Integration
- Regulatory-Grade Reliability
- Industry Leadership and Breadth
Criticised
- Competitive and Internal Alternatives
- High Cost and Limited Flexibility
What Certara customers say
Regulatory-Grade Reliability
“I would recommend Certara because their tools and services are highly reliable, audit‑ready, and well‑aligned with regulatory expectations, which is essential for clinical and pharmacometric work.”
Industry Leadership and Breadth
“Certara is a leader in the field and one of the best options for pharmacometrics, QSP, and clinical pharmacology. I would recommend it without hesitation to teams supporting regulated drug development who need trusted, validated tools.”
AI and Automation Integration
“We would consider switching vendors if a solution offered greater automation, faster delivery timelines, and fewer manual steps. AI could realistically replace much of the tool’s current functionality by reducing human error, accelerating statistical workflows, and generating reproducible outputs automatically.”
Renewal intent
Plan to renew 47%Plan to renew, by seniority
- 20% 5 answers
- 63% 8 answers
- 0% 1 answer
- 100% 1 answer
- 9/10 Average score from customers who will renew
- 7.3/10 Average score from undecided customers
- 7/10 Average score from customers not renewing
Report
For people who use Certara
Do you use Certara at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 19 customers of Certara have already contributed
Takes a few minutes. Your identity stays anonymous.